Received: 24-11-2014 Accepted 26-11-2014 Available Online 10-01-2015 Celal Bayar University, Faculty of Medicine, Department of Emergency Medicine, Manisa, Turkey Merkez Efendi State Hospital, Department of Clinical Biochemistry, Manisa, Turkey Prof. Dr. A. Ilhan Ozdemir State Hospital, Department of Neurology, Giresun, Turkey *Corresponding Author: Yalcin Golcuk E-mail: [email protected]...

BACKGROUND AND PURPOSE Depression after stroke is common. Like stroke, transient ischemic attack (TIA) is a manifestation of long-term atherosclerotic damage to the brain. However, the risk of depression developing after a TIA is uncertain. We studied whether TIA increases the risk of incident late-life depression. METHODS A cohort study of 5095 inhabitants of Rotterdam, the Netherlands, was ...

C onsidered a medical emergency, a transient ischemic attack (TIA) resulting from a focal ischemia in the brain or retina signals a sudden neurological deficit with patient symptoms typically lasting only 1 to 2 hours. The 90-day risk of stroke after a TIA is reported as high as 17% with the highest risk occurring in the first week. Approximately 240 000 US adults each year experience a TIA. 5 ...

Prognosis in Patients With Transient Ischemic A ttacks • The prognosis on 144 patients with transient ischemic attacks was determined over a minimum period of three years by quantitating, at intervals, the number of attacks and also the neurological disability by means of a disability score. No patients had neurological disability at the initiation of the study. Total cervicocephalic angiograph...

BACKGROUND AND PURPOSE By definition, the symptoms of a transient ischemic attack (TIA) subside completely within 24 hours. Imaging studies show signs of persistent ischemic tissue damage in a substantial amount of patients with TIA. Cerebral infarction can cause permanent cognitive impairment. Whether permanent cognitive impairment occurs after TIA is unclear, as is its profile. METHODS Pati...

Within 3 weeks of the event, 505 patients with cerebral infarction, minor or major stroke, were randomly assigned to treatment with acetylsalicylic acid (ASA) 1.5 g/day or placebo in a double-blind clinical trial with a follow-up of 2 years in all patients. Primary events were considered to be recurrent stroke or death; secondary events, myocardial infarction and transient ischemic attack. Ther...

Within 3 weeks of the event, 505 patients with cerebral infarction, minor or major stroke, were randomly assigned to treatment with acetylsalicylic acid (ASA) 1.5 g/day or placebo in a double-blind clinical trial with a follow-up of 2 years in all patients. Primary events were considered to be recurrent stroke or death; secondary events, myocardial infarction and transient ischemic attack. Ther...

BACKGROUND AND PURPOSE Patients with stroke are more likely to have impaired autonomic nervous function and abnormal circadian blood pressure (BP) patterns. It remains unclear whether circadian BP patterns in patients with transient ischemic attack or minor stroke (National Institutes of Health Stroke Scale ≤3) differ from those in the normal population. METHODS Participants were assessed usi...

BACKGROUND AND PURPOSE Many randomized clinical trials have evaluated the benefit of long-term use of antiplatelet drugs in reducing the risk of new vascular events in patients with a recent transient ischemic attack or ischemic stroke. Evidence from these trials forms the basis for national and international guidelines for the management of nearly all such patients in clinical practice. Howeve...